Methotrexate (Amplio Pharma)

甲氨蝶呤 (Amplio Pharma)

Report date: 2025/07/22 17:53:37

Base Information

Drug NameMethotrexate (Amplio Pharma)
Drug Alias NameMethotrexate Forte (Amplio Pharma)NovoBioJectAMP-101
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDihydrofolate reductase inhibitors
TargetsDihydrofolate reductase
Therapy Area/IndicationsAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusClinical
Highest Status in ChinaN/A
Originator CompaniesAmplio Pharma BV
China Registration ClassN/A

Develop Information

Active CompaniesAmplio Pharma BV
Inactive CompaniesN/A
Active IndicationsAutoimmune Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A